Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.
about
Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated MacrophagesMetformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysisMetformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer PatientsDissecting the role of AMP-activated protein kinase in human diseases.Diabetes, pancreatic cancer, and metformin therapy.Is 5´-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory responseEffect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy.Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatinToward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems PharmacologyObesity and Cancer: An Angiogenic and Inflammatory Link.Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer.Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.The double-edged sword of AMPK signaling in cancer and its therapeutic implications.Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.Metformin as a Tool to Target Aging.Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.Superoxide increases angiotensin II AT1 receptor function in human kidney-2 cells.Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?Dysregulations in the PI3K pathway and targeted therapies for head and neck squamous cell carcinomaSP and KLF Transcription Factors in Digestive Physiology and Diseases.Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.Aging and Caloric Restriction Research: A Biological Perspective With Translational Potential.Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.Metformin: a review of its potential indications.PDGFR Signaling Mediates Hyperproliferation and Fibrotic Responses of Subsynovial Connective Tissue Cells in Idiopathic Carpal Tunnel Syndrome.Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug.Towards natural mimetics of metformin and rapamycin.Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells.A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells.Pleiotropic Effects of Metformin on Cancer
P2860
Q27348974-BE2A56DC-B922-4135-988B-E46E3472CB90Q28069605-AEA3A89F-2797-4D9D-986C-BB801C06AB2FQ28550674-1FFFA21C-9BA8-4850-8ABB-D8E8C5DD948EQ33682914-2D1E5526-D141-42AE-B4E1-A89C1D4A17E2Q34471173-C60D41A4-9036-4EFE-B070-6DC3E73A18EDQ35813290-0EA23249-6DE4-41F5-A8FE-41E9D3F65C99Q35916851-2AE91C0C-BC92-4C57-8679-314B4F3E976EQ35953756-683A2339-4952-4F56-BC32-1BE9EEF3C75FQ35979251-0FD68AAA-5245-4E30-8E76-C26E1E492C86Q36099266-9BB28668-AF1B-4516-9251-A7ABAC36F640Q36346026-682E05C0-B021-4D70-9EE4-B147F9617A2FQ36542331-61ABA809-B240-40F2-9011-29D4A767C347Q36759129-6D6767E4-753C-4842-90F9-B8C864E7E907Q37225520-1DF44116-7684-431E-9E2A-9B2387C5D9DFQ37430812-7FEBE360-6386-476A-B3DB-153A6B40718DQ37649687-355055C9-50E8-4F65-A263-FE99254A3AA6Q38313164-D591907C-BD68-453C-8F31-211D65CC5A8BQ38627909-FD378E86-BD73-4838-BBA2-7C211C75CFEBQ38711927-86B27079-1B54-4635-BB0E-F20D7C362597Q38728567-CB59017B-3000-477B-BA7A-41C66F4229C0Q38829871-00CFF821-9516-4344-8B9C-68B8AF973D16Q38865781-E6587148-EAC5-49BF-89E6-3427E906E283Q38899707-B57C4662-A208-472C-860A-8561EC52AB45Q38959004-E939C86A-65E6-4AEA-9024-11E8547080D7Q39040854-7770EEFF-56D7-432D-B3C7-0A3907ABBA56Q39097109-A2C8B5A9-450C-4148-8B2E-192EFDEA7FA5Q39214035-D1A72958-6F9E-4D83-84C2-A1584F60C2D3Q39238333-7F437877-5EBA-4A11-8187-3366F21C877AQ39397591-1F41C662-6FD9-4D3B-BD31-C17D48EAE14AQ39907903-A92F7629-C844-48AC-9D3E-B6E4C11451D1Q41545473-0698F376-DCA6-4A57-AE48-AB5C09DCFE4EQ47102830-AC80EB53-46E5-4267-AAFE-442C50D364F9Q47126247-974089AD-D67A-4071-8D21-79B971F4125AQ47140599-9DDB3CD9-1542-4C43-90F4-29DE5D9BFFB2Q49180657-409305F8-CF37-4131-B6C3-20DD320551F6Q55397017-1DEB7DAD-524A-470D-933F-DC721AE0BCE0Q59138314-8BEFDAFE-660B-47FE-8495-C422645433AE
P2860
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@ast
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@en
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin
@nl
type
label
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@ast
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@en
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin
@nl
prefLabel
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@ast
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@en
Mechanism of metformin-dependent inhibition of mammalian target of rapamycin
@nl
P2093
P2860
P356
P1476
Mechanism of metformin-depende ...... in (Sp) transcription factors.
@en
P2093
Ala Abudayyeh
Maen Abdelrahim
Sandeep Sreevalsan
Stephen Safe
Vijayalekshmi Nair
P2860
P304
27692-27701
P356
10.1074/JBC.M114.592576
P407
P577
2014-08-20T00:00:00Z